INTRODUCTION {#sec1-1}
============

The estimate of nonobstetric surgery among pregnant women in developed countries is around 0.75-2% and presents an important challenge for anesthesiologists. A successful maternal and fetal outcome is dependent on a thorough understanding of maternal and fetal physiology altered drug pharmacodynamics and pharmacokinetics to provide safe anesthesia to the mother and simultaneously minimize the risk of preterm labor.\[[@ref1]\] A multidisciplinary approach is essential to ensure maternal and fetal wellbeing throughout the perioperative period.\[[@ref2]\]

CASE REPORT {#sec1-2}
===========

A 25-year-old primigravida with 22 weeks gestation weighing 62 kg and height of 162 cm presented for a routine antenatal check-up. Patient was diagnosed with pancytopenia secondary to hypersplenism from chronic portal vein thrombosis with recanalization. She was scheduled for an open splenectomy in view of severe refractory pancytopenia.

The preanesthetic assessment revealed easy fatigability, which was otherwise not significant. She was administered vaccination against *Haemophilus influenza*, *Streptococcus pneumococcus*, and *Neisseria meningococcus* 10 days prior to surgery.

On physical examination, pallor was evident with stable vital signs. The abdominal examination revealed moderate splenomegaly and uterus corresponding to 20 weeks of gestation. Respiratory and cardiovascular system was normal on examination. Airway assessment was not suggestive of a difficult airway.

All the relevant laboratory investigations were done, and it was noted that the hemoglobin was 7.8 g%, platelet count was 25.0 × 10^3^/μL, and the total white blood cell count was 1.7 × 10^3^/μL. The peripheral smear revealed microcytic hypochromic anemia with a reduced number of white blood cells and platelets. Bone marrow aspiration was also carried out and was suggestive of iron deficiency anemia.

Upper gastrointestinal scopy showed esophageal varices while the ultrasound abdomen diagnosed features of chronic portal vein thrombosis with recanalization, gross splenomegaly with minimal ascites.

In the preoperative period, a written informed consent was obtained from the lady after counseling about risks and benefits of intervention. She was also taught regarding deep breathing techniques and incentive spirometry. Arrangement of blood and blood products was done for the perioperative period. A preoperative fetal cardiotocography and ultrasound revealed that the fetus was well and concordant with its gestational age.

Patient was advised tocolysis with intramuscular injection progesterone 500 mg. Preoperatively, patient was kept nil by mouth for 8 h. Oral premedication with tablet alprazolam 0.25 mg, intravenous (IV) ranitidine 50 mg, and IV metoclopramide 10 mg was administered.

During the intraoperative period, standard monitoring was commenced with electrocardiogram (Lead II and V5), noninvasive blood pressure (BP) and peripheral O~2~ saturation, in the operating room. IV access was secured with a 16-gauge cannula. Preoxygenation was done for 5 min with 100% oxygen. Rapid sequence induction was done with IV propofol-150 mg, IV fentanyl 100 μg, and IV succinylcholine 75 mg with application of cricoid pressure. Postinduction another 16-gauge cannula was placed. The trachea was orally intubated with 7.0 mm cuffed endotracheal tube at the first attempt without any difficulty.

The patient was positioned supine with a left uterine displacement accomplished by placing a wedge under the right hip \[[Figure 1](#F1){ref-type="fig"}\].

![General anesthesia being administered to the pregnant patient](AER-8-393-g001){#F1}

General anesthesia (GA) was maintained with fentanyl infusion of 0.5-1 μg/kg/h, 0.6-0.8 minimum alveolar concentration isoflurane with 50% oxygen in the air controlled ventilation via circle system with tidal volume 8 ml/kg sustaining an end-tidal CO~2~ values at 35 ± 2 mm Hg. The blood loss was replaced with 1 L colloid. Eight units of random donor platelets were administered following the ligation of splenic vessels, followed by transfusion of four units of packed cells and four units of fresh frozen plasma. The intraoperative blood loss amounted to around 2.5 L. Splenectomy was performed, hemostasis was achieved \[[Figure 2](#F2){ref-type="fig"}\]. The procedure lasted for 4 h. The maternal heart rate and BP remained within normal limits during surgery.
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At the end of surgery, the neuromuscular blockade was reversed, and prophylactic antiemetic was administered. The patient was extubated once fully awake in the operating room and transported to intensive care unit uneventfully.

In the postoperative period, pain management was done by administration of IV fentanyl 1-2 μg/kg/h. Deep breathing exercises, incentive spirometry, and chest physiotherapy were continued.

The follow-up fetal ultrasound was noteworthy and revealed no changes from the preprocedure baseline. Repeat laboratory data after 4 h revealed hemoglobin of 11.2 g % and platelet count of 95 × 10^3^/μL.

DISCUSSION {#sec1-3}
==========

Hypersplenism resulting from chronic portal vein thrombosis during pregnancy may require urgent surgical intervention due to worsening pancytopenia. However, there are several unique anesthetic considerations to be kept in mind to ensure maternal safety due to anatomical, physiological, and pharmacological changes that take place during pregnancy. Ensuring fetal wellbeing necessitates avoidance of teratogenic drugs during critical times of fetal development, maintenance of stable maternal hemodynamic parameters, and oxygenation for adequate uteroplacental perfusion, close fetal monitoring to identify early signs of fetal distress and avoidance or treatment of preterm labor/delivery.

In our anesthetic management preoperatively, aspiration prophylaxis was administered. Rapid sequence IV induction of GA was preceded by meticulous preoxygenation and application of effective cricoid pressure. A smaller size endotracheal tube 7.0 mm was used due to respiratory tract mucosa edema and vascular engorgement associated with pregnancy. Positioning with a 20° left lateral tilt was used to facilitate uterine displacement as aortocaval compression is a matter of concern to anesthesiologist during and after the second trimester.\[[@ref3]\]

In performing an essential surgery like splenectomy for declining hematological parameters, timing of surgery needs a balancing between maternal and fetal risks and urgency of surgery. The second trimester is safe for the fetus for timing nonobstetric surgery during pregnancy.\[[@ref4]\] Teratogenicity of anesthetic drugs depends on the dose administered, route administered, and time of exposure.\[[@ref3]\] Although there are no anesthetic agents proven to be teratogens, pregnant patients should be exposed to the fewest drugs possible and at the lowest concentrations clinically indicated.\[[@ref4]\] The 15^th^ to 56^th^ days of gestation of the human embryo is the most vulnerable to teratogenic effects of the drug.\[[@ref5]\] Most of the anesthetic drugs have good safety record for use during pregnancy. However, subtle associations cannot be ruled out.\[[@ref1]\] From 18 to 22 weeks, fetal heart rate (FHR) monitoring is essential to assess fetal well-being during surgery and anesthesia.\[[@ref3]\] Therefore, a multi-disciplinary approach with a senior obstetrician involvement needs to be established early in the management. In our situation, we had liaison with obstetrician, pediatrician, and surgeon, but FHR monitoring was not technically feasible as the procedure was an abdominal surgery. However, a fetal ultrasound was performed by the obstetricians just before shifting the patient to the operating room and also in the immediate postoperative period.

There is an enhanced risk of preterm labor after abdominal and pelvic surgeries suggesting that the mechanical perturbation, local inflammation or both risk factors of women who had surgery, 54% received GA, which included nitrous oxide in 97% of cases. There was no increased incidence of stillbirth or congenital anomalies but an increased incidence of prematurity and intrauterine growth restriction (\<1.5 kg) in the surgical group, increased rate of neural tube effects with exposure in the 1^st^ trimester.\[[@ref1]\] The routine administration of prophylactic tocolytics is controversial and generally limited to those patients in whom there has been manipulation of the uterus intraoperatively.\[[@ref3]\] Provision of adequate analgesia is also important in the postoperative period as pain has shown to increase the risk of premature labor. If pregnancy continues beyond the first postoperative week, then the incidence of preterm labor is no higher than the nonsurgical pregnant patients.\[[@ref2]\] In this case, patient was followed up, and she delivered at term with no occurrence of congenital anomaly.

Considerations in relation to splenectomy {#sec2-1}
-----------------------------------------

Pregnant patients with splenomegaly often present with diverse coexisting medical disease thereby offer variety of anesthetic considerations. The challenges include massive intraoperative hemorrhage, perioperative coagulation abnormalities, and postsplenectomy infection.\[[@ref6]\] Hypersplenism necessitates immediate availability of blood products when brisk bleeding occurs. Thrombocytopenia requires the administration of platelets following ligation of splenic vessels (to decrease sequestration). All postsplenectomy patients carry risk of infection although vaccination and prophylactic antibiotic regimen have reduced infection-related morbidity and mortality.\[[@ref7]\] There is also a higher incidence of postoperative pulmonary complication such as basal atelectasis and pneumonia. Adequate postoperative analgesia improves the pattern and effectiveness of ventilation. In addition, chest physiotherapy, deep breathing exercises, and incentive spirometry are supportive in decreasing the incidence of left lower lobe atelectasis.\[[@ref6]\]

CONCLUSION {#sec1-4}
==========

Successful outcome in administration of GA in a pregnant patient for nonobstetric surgery is dependent on meticulous understanding of physiological and pharmacological adaptations to pregnancy to ensure maternal safety. Fetal safety requires avoidance of a dangerous drug at critical times during development, continuation of uteroplacental perfusion and avoidance/treatment of preterm labor.

**Source of Support:** Nil

**Conflict of Interest:** None declared.
